With a uniquely cross-disciplinary career spanning agricultural biotech and clinical genomics, Danny De Sloover has built and scaled innovative sequencing and genetic analysis systems across both industries. From early work at Dow (now Corteva) advancing genome editing (ZFNs) and next-generation sequencing (Solexa -> Illumina, 454, PacBio) for crop improvement, to developing ultra-deep tumor profiling assays in the clinical space, their experience bridges cutting-edge science with real-world application.
As a founding lab member at Color, Danny helped create a clinical sequencing operation that delivered over one million results, emphasizing human-centered design and clear communication of complex data. Most recently, Danny led large-scale metagenomic efforts in agriculture at Pattern Ag, translating sophisticated biological insights from shotgun metagenome sequencing into actionable outcomes for row-crop farmers